Hua Jasmine Song

Array ( [id] => 4567585 [patent_doc_number] => 07847067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Antibodies to NTB-A' [patent_app_type] => utility [patent_app_number] => 12/096877 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 46583 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/847/07847067.pdf [firstpage_image] =>[orig_patent_app_number] => 12096877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479002 [patent_doc_number] => 20100092457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/308695 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32441 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092457.pdf [firstpage_image] =>[orig_patent_app_number] => 12308695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915628 [patent_doc_number] => 20080096228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Compositions And Methods Relating To Mammalian Internal Ribosome Entry Sites' [patent_app_type] => utility [patent_app_number] => 11/835974 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9258 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096228.pdf [firstpage_image] =>[orig_patent_app_number] => 11835974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4692470 [patent_doc_number] => 20080085241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Antibody' [patent_app_type] => utility [patent_app_number] => 11/835010 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22467 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085241.pdf [firstpage_image] =>[orig_patent_app_number] => 11835010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825052 [patent_doc_number] => 20080124366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Methods and Compositions for Treating Tumors' [patent_app_type] => utility [patent_app_number] => 11/834483 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18295 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124366.pdf [firstpage_image] =>[orig_patent_app_number] => 11834483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496353 [patent_doc_number] => 20090264381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 151P3D4 USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/833918 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 267433 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264381.pdf [firstpage_image] =>[orig_patent_app_number] => 11833918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515685 [patent_doc_number] => 20090215992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Dual variable domain immunoglobulin and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/890215 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 83710 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215992.pdf [firstpage_image] =>[orig_patent_app_number] => 11890215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915167 [patent_doc_number] => 20080095767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'ENGINEERED ANTIBODIES WITH NEW WORLD PRIMATE FRAMEWORK REGIONS' [patent_app_type] => utility [patent_app_number] => 11/832553 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16387 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095767.pdf [firstpage_image] =>[orig_patent_app_number] => 11832553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9704111 [patent_doc_number] => 08829175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Nucleic acids encoding polyvalent protein complexes' [patent_app_type] => utility [patent_app_number] => 11/830413 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 32684 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11830413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582638 [patent_doc_number] => 20100129929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Tyrosine Phosphorylation Sites' [patent_app_type] => utility [patent_app_number] => 12/309727 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 41382 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12309727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15132755 [patent_doc_number] => 10479824 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Single chain FC polypeptides [patent_app_type] => utility [patent_app_number] => 12/374213 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 13955 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420316 [patent_doc_number] => 20100150927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'CELL DEATH INDUCER' [patent_app_type] => utility [patent_app_number] => 12/307042 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21878 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150927.pdf [firstpage_image] =>[orig_patent_app_number] => 12307042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4803749 [patent_doc_number] => 20080015338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Individualized anti-cancer antibodies' [patent_app_type] => utility [patent_app_number] => 11/774293 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6705 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015338.pdf [firstpage_image] =>[orig_patent_app_number] => 11774293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10096973 [patent_doc_number] => 09133274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Method for engineering immunoglobulins' [patent_app_type] => utility [patent_app_number] => 12/307569 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29771 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12307569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687706 [patent_doc_number] => 20080031887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Conjugates for inducing targeted immune responses and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 11/823921 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18873 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031887.pdf [firstpage_image] =>[orig_patent_app_number] => 11823921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10115779 [patent_doc_number] => 09150650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof' [patent_app_type] => utility [patent_app_number] => 12/664226 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 35 [patent_no_of_words] => 21532 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12664226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948985 [patent_doc_number] => 20080305111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Anti-C35 antibodies for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/812996 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 57528 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305111.pdf [firstpage_image] =>[orig_patent_app_number] => 11812996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545585 [patent_doc_number] => 08053557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same' [patent_app_type] => utility [patent_app_number] => 12/304350 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8069 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053557.pdf [firstpage_image] =>[orig_patent_app_number] => 12304350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832881 [patent_doc_number] => 20080131428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of TROP-2' [patent_app_type] => utility [patent_app_number] => 11/807837 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 27609 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131428.pdf [firstpage_image] =>[orig_patent_app_number] => 11807837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669357 [patent_doc_number] => 20080044417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Humanized Fc.gamma.RIIB-Specific Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/754015 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 72446 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044417.pdf [firstpage_image] =>[orig_patent_app_number] => 11754015 [rel_patent_id] =>[rel_patent_doc_number] =>)